Detalhe da pesquisa
1.
5'-nucleotidase, cytosolic II genotype, and clinical outcome in patients with acute myeloid leukemia with intermediate-risk cytogenetics.
Eur J Haematol
; 109(6): 755-764, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36063368
2.
Relevance of infections on the outcomes of patients with myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia treated with hypomethylating agents: a cohort study from the GESMD.
Ther Adv Hematol
; 13: 20406207221127547, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36199837
3.
UGT1A1 genotype influences clinical outcome in patients with intermediate-risk acute myeloid leukemia treated with cytarabine-based chemotherapy.
Leukemia
; 34(11): 2925-2933, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32152464